This article provides a comprehensive guide to the mathematical models that define the in vivo behavior of Chimeric Antigen Receptor T (CAR-T) cells.
This article provides a comprehensive analysis of the critical challenges and solutions in CAR-T cell manufacturing variability for researchers, scientists, and drug development professionals.
This comprehensive guide details current best practices for CAR-T cell culture and expansion, targeting researchers, scientists, and drug development professionals.
This article provides a detailed and up-to-date analysis of CAR-NK (Chimeric Antigen Receptor-Natural Killer) cell therapy, a rapidly evolving frontier in immuno-oncology and drug development.
This article provides a comprehensive review of the validation and application of the CAR-HEMATOTOX (HT) score, a predictive model for prolonged cytopenias and infectious complications following CD19-directed CAR T-cell therapy.
This article provides a comprehensive overview of bulk RNA-seq deconvolution for estimating immune cell infiltration, a critical technique in immunology and immuno-oncology research.
Immune checkpoint inhibitors (ICIs) have transformed oncology, but not all patients respond, highlighting a critical need for predictive biomarkers.
This article provides a comprehensive roadmap for researchers and drug development professionals navigating the complex landscape of biomarker validation for immunotherapy.
This comprehensive review synthesizes current research on biomarkers for predicting response to immunotherapy.
This comprehensive guide provides researchers, scientists, and drug development professionals with a practical framework for successful cancer biomarker development.